Can patients who use electronic (e-) cigarettes undergo lung cancer screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lung Cancer Screening for Electronic Cigarette Users

Electronic cigarette users do not currently qualify for lung cancer screening under established guidelines, as eligibility criteria are specifically based on combustible cigarette smoking history rather than e-cigarette use. 1, 2

Current Lung Cancer Screening Eligibility Criteria

The most recent NCCN Guidelines (Version 1.2025) clearly define eligibility for lung cancer screening based on:

  • Group 1: Individuals aged 50-80 years with a ≥20 pack-year history of combustible cigarette smoking who currently smoke or have quit within the past 15 years 1, 2
  • Group 2: Individuals aged ≥50 years with a ≥20 pack-year history of combustible cigarette smoking plus at least one additional risk factor (such as occupational exposure to lung carcinogens, radon exposure, personal cancer history, family history of lung cancer, or lung disease) 1

Why E-Cigarette Users Don't Currently Qualify

Several important points explain why e-cigarette users don't qualify:

  • Cigarette-specific criteria: All major guidelines (NCCN, USPSTF, American Cancer Society) specifically define eligibility based on combustible cigarette smoking history measured in pack-years 1, 2
  • Evidence gap: The landmark National Lung Screening Trial (NLST) and other studies that established the mortality benefit of screening were conducted in combustible cigarette smokers, not e-cigarette users 1
  • Pack-year calculation: The definition of pack-years is explicitly tied to cigarettes: "number of packs of cigarettes smoked every day multiplied by the number of years of smoking" 1

E-Cigarette Use in Lung Cancer Screening Populations

Research shows that:

  • Approximately 39.8% of individuals eligible for lung cancer screening report ever using e-cigarettes, while 8.9% report current e-cigarette use 3
  • Some patients attending lung cancer screening who smoke combustible cigarettes express interest in switching to e-cigarettes for harm reduction 4
  • However, this data reflects e-cigarette use among those who already qualify for screening based on their combustible cigarette smoking history

Clinical Implications and Recommendations

  1. Screening eligibility assessment: When evaluating patients for lung cancer screening eligibility, focus specifically on combustible cigarette smoking history, not e-cigarette use 1, 2

  2. Documentation: Document e-cigarette use separately from combustible cigarette smoking history, as they are not equivalent for screening eligibility purposes

  3. Patient education: Inform e-cigarette users that:

    • Current screening guidelines do not include e-cigarette use in eligibility criteria
    • The long-term health effects of e-cigarettes are still being studied
    • Screening may be recommended in the future as evidence evolves
  4. Smoking cessation opportunity: Lung cancer screening represents a "teachable moment" for smoking cessation interventions 5, which could include discussions about both combustible cigarettes and e-cigarettes

Future Considerations

As research on e-cigarettes evolves, screening guidelines may be updated to address this population. Currently, there is insufficient evidence to recommend lung cancer screening based on e-cigarette use alone.

For patients who use both combustible cigarettes and e-cigarettes, eligibility should be determined based solely on their combustible cigarette smoking history according to established criteria 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.